Nothing Special   »   [go: up one dir, main page]

ATE284712T1 - Medizinische zusammensetzungen zur förderung der aktivierung der eingeweide - Google Patents

Medizinische zusammensetzungen zur förderung der aktivierung der eingeweide

Info

Publication number
ATE284712T1
ATE284712T1 AT01925974T AT01925974T ATE284712T1 AT E284712 T1 ATE284712 T1 AT E284712T1 AT 01925974 T AT01925974 T AT 01925974T AT 01925974 T AT01925974 T AT 01925974T AT E284712 T1 ATE284712 T1 AT E284712T1
Authority
AT
Austria
Prior art keywords
adenosine
defecation
receptor antagonists
activation
medicinal compositions
Prior art date
Application number
AT01925974T
Other languages
English (en)
Inventor
Masahiro Yasuda
Hitoshi Harada
Shuhei Miyazawa
Seiichi Kobayashi
Kokichi Harada
Takayuki Hida
Hisashi Shibata
Nobuyuki Yasuda
Osamu Asano
Yoshihiko Kotake
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Application granted granted Critical
Publication of ATE284712T1 publication Critical patent/ATE284712T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • A61K31/522Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53771,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • HELECTRICITY
    • H04ELECTRIC COMMUNICATION TECHNIQUE
    • H04BTRANSMISSION
    • H04B10/00Transmission systems employing electromagnetic waves other than radio-waves, e.g. infrared, visible or ultraviolet light, or employing corpuscular radiation, e.g. quantum communication
    • H04B10/11Arrangements specific to free-space transmission, i.e. transmission through air or vacuum
    • H04B10/112Line-of-sight transmission over an extended range

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Electromagnetism (AREA)
  • Signal Processing (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT01925974T 2000-04-26 2001-04-26 Medizinische zusammensetzungen zur förderung der aktivierung der eingeweide ATE284712T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000126489 2000-04-26
JP2000220124 2000-07-21
PCT/JP2001/003643 WO2001080893A1 (fr) 2000-04-26 2001-04-26 Compositions medicinales favorisant les mouvements intestinaux

Publications (1)

Publication Number Publication Date
ATE284712T1 true ATE284712T1 (de) 2005-01-15

Family

ID=26590887

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01925974T ATE284712T1 (de) 2000-04-26 2001-04-26 Medizinische zusammensetzungen zur förderung der aktivierung der eingeweide

Country Status (16)

Country Link
US (3) US7189717B2 (de)
EP (2) EP1283056B1 (de)
JP (1) JP4128360B2 (de)
KR (2) KR20070058022A (de)
CN (1) CN1197621C (de)
AT (1) ATE284712T1 (de)
AU (2) AU2001252606B2 (de)
CA (1) CA2407013A1 (de)
DE (1) DE60107835T2 (de)
HU (1) HUP0300927A2 (de)
IL (2) IL152023A0 (de)
MX (1) MXPA02010552A (de)
NO (1) NO20025116L (de)
NZ (1) NZ521633A (de)
RU (2) RU2294762C2 (de)
WO (1) WO2001080893A1 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0300927A2 (hu) 2000-04-26 2003-07-28 Eisai Co., Ltd. Új pirimidinszármazékok és ezeket tartalmazó defekációt elősegítő gyógyszerkészítmények
TWI301834B (en) 2001-10-22 2008-10-11 Eisai R&D Man Co Ltd Pyrimidone compound and pharmaceutical composition including the same
TWI330183B (de) 2001-10-22 2010-09-11 Eisai R&D Man Co Ltd
ES2686123T3 (es) 2002-01-28 2018-10-16 Kyowa Hakko Kogyo Co., Ltd Antagonistas del receptor A2A para su uso en el tratamiento de trastornos del movimiento
WO2003084936A2 (en) * 2002-04-10 2003-10-16 Orchid Chemicals & Pharmaceuticals Limited Amino substituted pyrimidinone derivatives useful in the treatment of inflammation and immunological
ES2229928B1 (es) * 2003-10-02 2006-07-01 Almirall Prodesfarma, S.A. Nuevos derivados de pirimidin-2-amina.
JP2007514003A (ja) * 2003-12-15 2007-05-31 アルミラル プロデスファルマ アーゲー アデノシン受容体アンタゴニストとしての2,6−ビスヘテロアリール−4−アミノピリミジン
SE0400233D0 (sv) * 2004-02-04 2004-02-04 Ltp Lipid Technologies Provide Rektal komposition
EP1738766A4 (de) * 2004-03-30 2010-05-12 Kyowa Hakko Kirin Co Ltd Mittel zur prävention und/oder behandlung von erkrankungen mit chronischen/knochenschmerzen
ES2241496B1 (es) * 2004-04-15 2006-12-01 Almirall Prodesfarma, S.A. Nuevos derivados de piridina.
US20080275064A1 (en) * 2005-04-11 2008-11-06 Deborah Slee Substituted Pyrimidines as Adenosine Receptor Antagonists
EP1871762A2 (de) * 2005-04-18 2008-01-02 Neurogen Corporation Substituierte heteroaryle als cb1-antagonisten
ES2270715B1 (es) 2005-07-29 2008-04-01 Laboratorios Almirall S.A. Nuevos derivados de pirazina.
ES2274712B1 (es) 2005-10-06 2008-03-01 Laboratorios Almirall S.A. Nuevos derivados imidazopiridina.
ES2273599B1 (es) 2005-10-14 2008-06-01 Universidad De Barcelona Compuestos para el tratamiento de la fibrilacion auricular.
FR2902010B1 (fr) * 2006-06-12 2008-08-22 Pierre Fabre Medicament Sa Utilisation de la 1,7 dimethylxanthine pour la fabrication d'un medicament psychoanaleptique non anxiogene destine au traitement d'un trouble neuropsychiatrique
US20080009623A1 (en) * 2006-07-06 2008-01-10 Eisai R&D Management Co., Ltd. Pyrimidine compounds
US8227027B2 (en) * 2007-12-07 2012-07-24 Presspart Gmbh & Co. Kg Method for applying a polymer coating to an internal surface of a container
JP5460690B2 (ja) 2008-03-26 2014-04-02 アドヴィナス・セラピューティックス・リミテッド アデノシンレセプターアンタゴニストとしてのヘテロ環化合物
TWI473614B (zh) 2008-05-29 2015-02-21 Kyowa Hakko Kirin Co Ltd Anti-analgesic inhibitors
JP5426156B2 (ja) * 2008-12-25 2014-02-26 フマキラー株式会社 排便促進用組成物
AU2010222289B2 (en) 2009-03-13 2013-07-11 Advinus Therapeutics Private Limited Substituted fused pyrimidine compounds
US8796290B2 (en) 2009-11-09 2014-08-05 Advinus Therapeutics Limited Substituted fused pyrimidine compounds, its preparation and uses thereof
US8940751B2 (en) 2010-09-13 2015-01-27 Advinus Therapeutics Private Limited Purine compounds as prodrugs of A2B adenosine receptor antagonists, their process and medicinal applications
GB201106829D0 (en) 2011-04-21 2011-06-01 Proximagen Ltd Heterocyclic compounds
RU2014108140A (ru) 2011-08-04 2015-09-10 Эррэй Биофарма Инк. Соединение на основе хинозолина в качестве ингибиторов серен-треониновых киназ
CA2864085C (en) 2012-02-08 2021-11-23 Sunovion Pharmaceuticals Inc. Heteroaryl compounds and methods of use thereof
JP6068515B2 (ja) 2012-03-01 2017-01-25 アレイ バイオファーマ、インコーポレイテッド セリン/トレオニンキナーゼ阻害剤
CA2882750A1 (en) 2012-08-27 2014-03-06 Jim Blake Serine/threonine kinase inhibitors for the treatment of hyperproliferative|diseases
ES2580702B1 (es) * 2015-02-25 2017-06-08 Palobiofarma, S.L. Derivados de 2-aminopiridina como antagonistas del receptor A2b de adenosina y ligandos del receptor MT3 de melatonina
JP2017149663A (ja) * 2016-02-24 2017-08-31 株式会社Lttバイオファーマ 過敏性腸症候群治療剤
CN105687225B (zh) * 2016-02-26 2018-07-06 四川好医生攀西药业有限责任公司 一种治疗肠易激综合征的药物组合物及其制备方法和应用
JP7187437B2 (ja) 2016-07-29 2022-12-12 サノビオン ファーマシューティカルズ インク 化合物および組成物ならびにそれらの使用
US11077090B2 (en) 2016-07-29 2021-08-03 Sunovion Pharmaceuticals Inc. Compounds and compositions and uses thereof
AU2018312559B2 (en) 2017-08-02 2022-06-02 Pgi Drug Discovery Llc Isochroman compounds and uses thereof
WO2019121374A1 (en) * 2017-12-20 2019-06-27 Basf Se Herbicidal pyrimidine compounds
CN112423758A (zh) * 2018-07-10 2021-02-26 尼康治疗公司 腺苷受体结合化合物
WO2020083957A1 (en) * 2018-10-24 2020-04-30 Leadxpro Ag Functionalized aminotriazines
CN113784755B (zh) 2019-03-14 2024-05-10 赛诺维信制药公司 异色满基化合物的盐及其结晶形式、制备方法、治疗用途和药物组合物

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4725600A (en) * 1984-07-13 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Pyrimidine compounds having activity as a cardiotonic anti-hypertensive cerebrovascular vasodilator and anti-platelet aggregation agent
US4673680A (en) 1985-09-18 1987-06-16 Pendleton Robert G α2 -adrenergic receptor antagonists as modifiers of gastrointestinal motility
JPH06102662B2 (ja) 1989-09-01 1994-12-14 協和醗酵工業株式会社 キサンチン誘導体
JPH04271770A (ja) 1991-02-27 1992-09-28 Asahi:Kk お茶
JP3343965B2 (ja) * 1992-10-31 2002-11-11 ソニー株式会社 音声符号化方法及び復号化方法
CN1088053A (zh) 1993-01-04 1994-06-22 谷中村 一种益寿保健茶叶
JPH06211669A (ja) 1993-01-14 1994-08-02 Kyowa Hakko Kogyo Co Ltd 腸運動の異常亢進治療剤
WO1994016702A1 (en) * 1993-01-26 1994-08-04 Kyowa Hakko Kogyo Co., Ltd. Remedy for irregular bowel movement
JP3123286B2 (ja) * 1993-02-18 2001-01-09 ソニー株式会社 ディジタル信号処理装置又は方法、及び記録媒体
GB9309573D0 (en) * 1993-05-10 1993-06-23 Merck Sharp & Dohme Therapeutic agents
JP3277679B2 (ja) * 1994-04-15 2002-04-22 ソニー株式会社 高能率符号化方法と高能率符号化装置及び高能率復号化方法と高能率復号化装置
WO1997033883A1 (en) * 1996-03-13 1997-09-18 Smithkline Beecham Corporation Novel pyrimidine compounds useful in treating cytokine mediated diseases
AUPO111096A0 (en) * 1996-07-18 1996-08-08 Fujisawa Pharmaceutical Co., Ltd. New compound
US6096753A (en) * 1996-12-05 2000-08-01 Amgen Inc. Substituted pyrimidinone and pyridone compounds and methods of use
KR100476586B1 (ko) 1996-12-05 2005-03-18 암젠 인코포레이티드 치환된 피리미딘온 화합물과 이 화합물을 포함하는 제약학적 조성물 및 치료방법
TW520362B (en) 1996-12-05 2003-02-11 Amgen Inc Substituted pyrimidine compounds and pharmaceutical composition comprising same
JP3990061B2 (ja) 1998-01-05 2007-10-10 エーザイ・アール・アンド・ディー・マネジメント株式会社 プリン誘導体および糖尿病の予防・治療剤としてのアデノシンa2受容体拮抗剤
EP1054012B1 (de) * 1998-01-05 2003-06-11 Eisai Co., Ltd. Purinderivate und antagonisten des adenosin-a2-rezeptors, welche zur vorsorge oder heilung von diabetes dienen
CA2239294A1 (en) * 1998-05-29 1999-11-29 Majid Foodeei Methods and apparatus for efficient quantization of gain parameters in glpas speech coders
MXPA00011889A (es) 1998-06-02 2003-04-25 Osi Pharm Inc Composiciones de pirrolo (2,3d) piridina y su uso.
AU4506399A (en) 1998-06-05 1999-12-30 Novartis Ag Aryl pyridinyl thiazoles
HUP0103025A3 (en) * 1998-06-23 2002-04-29 Glaxo Group Ltd A2a agonist 2-(purin-9-yl)tetrahydrofuran-3,4-diol derivatives, medicaments containing the same, process for producing them and the useful intermediates
AR023052A1 (es) 1998-09-25 2002-09-04 Mitsuharu Yoshimura Milton Derivados de pirimidona
AUPP672198A0 (en) * 1998-10-23 1998-11-19 Fujisawa Pharmaceutical Co., Ltd. Pyrazolopyridine compound and pharmaceutical use thereof
FR2791167B1 (fr) * 1999-03-17 2003-01-10 Matra Nortel Communications Procedes de codage, de decodage et de transcodage audio
WO2001002400A1 (fr) 1999-07-02 2001-01-11 Eisai Co., Ltd. Composes imidazole fusionnes et medicaments contre le diabete sucre
EP1136486A1 (de) 2000-03-23 2001-09-26 Sanofi-Synthelabo 2-(Indanylamino)pyrimidon und 2-(Tetrahydronaphtalenylamino)pyrimidinon Derivate
EP1136482A1 (de) 2000-03-23 2001-09-26 Sanofi-Synthelabo 2-Amino-3-(alkyl)-pyrimidonderivate als GSK3beta-Hemmer
AU2001248365A1 (en) 2000-03-23 2001-10-03 Mitsubishi Pharma Corporation 2-(arylalkylamino)pyrimidone derivatives and 2-(heteroarylalkylamino)pyrimidone derivatives
HUP0300927A2 (hu) 2000-04-26 2003-07-28 Eisai Co., Ltd. Új pirimidinszármazékok és ezeket tartalmazó defekációt elősegítő gyógyszerkészítmények

Also Published As

Publication number Publication date
US20070054876A1 (en) 2007-03-08
EP1283056B1 (de) 2004-12-15
EP1283056A1 (de) 2003-02-12
MXPA02010552A (es) 2003-03-10
IL188052A0 (en) 2008-03-20
CN1426310A (zh) 2003-06-25
US7189717B2 (en) 2007-03-13
IL152023A0 (en) 2003-04-10
AU5260601A (en) 2001-11-07
EP1510222A2 (de) 2005-03-02
NO20025116D0 (no) 2002-10-24
RU2005127415A (ru) 2007-03-10
AU2001252606B2 (en) 2005-07-07
RU2002131637A (ru) 2004-03-27
EP1283056A4 (de) 2003-07-02
US20030171383A1 (en) 2003-09-11
CN1197621C (zh) 2005-04-20
DE60107835T2 (de) 2005-12-22
KR20020089495A (ko) 2002-11-29
JP4128360B2 (ja) 2008-07-30
NZ521633A (en) 2005-01-28
US20060270674A1 (en) 2006-11-30
NO20025116L (no) 2002-12-23
EP1510222A3 (de) 2007-05-23
KR20070058022A (ko) 2007-06-07
WO2001080893A1 (fr) 2001-11-01
KR100782091B1 (ko) 2007-12-04
DE60107835D1 (de) 2005-01-20
CA2407013A1 (en) 2002-10-22
HUP0300927A2 (hu) 2003-07-28
RU2294762C2 (ru) 2007-03-10

Similar Documents

Publication Publication Date Title
ATE284712T1 (de) Medizinische zusammensetzungen zur förderung der aktivierung der eingeweide
ES2172592T3 (es) Agente antagonista de progesterona y agente gestageno para el tratamiento de la endometriosis y del liomioma uterino.
DE69419527D1 (de) Laxiermittel das ballastfasern und dioctyl-sulfosuccinat enthält
CA2321523A1 (en) Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants
HUT75930A (en) Progesterone antagonists useful preparing medicaments for treating dysfunctional uterine bleeding
ATE272628T1 (de) Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen
DE69932510D1 (de) Vaskularisierungsinhibitoren
CA2408537A1 (en) Treating irritable bowel syndrome or disease
RU2210573C2 (ru) Углеводные производные
WO2001076638A3 (en) Compositions for drug delivery
DE59813162D1 (de) Pharmazeutische zusammensetzung enthaltend clindamycin und clotrimazol, zur behandlung vaginaler infektionen
NZ514696A (en) IL-8 receptor antagonists
BR9909971A (pt) Uso de um composto, processo para tratamento ou prevenção da sìndrome de intestinos irritáveis, e, composição farmacêutica para o tratamento da sìndrome dos intestinos irritáveis
MX9705916A (es) Terapia de combinacion para infeccion por vih usando el inhibidor de proteasa de vih indinavir y el inhibidor de transcriptasa inversa 3tc, opcionalmente junto con azt, ddi, o ddc.
BR9507848A (pt) Composição farmcéutica contendo espiramicina eventualmente em associação com o metronizadol
NZ515232A (en) IL-8 receptor antagonists
DE60126504D1 (de) Verwendung von gegen candida wirksamen mitteln zur behandlung von störungen der oralen und intestinalen mucosa
UA37427A (uk) Пристрій для очищення прямої кишки
ES2172818T3 (es) Uso de antagonistas de lh-rh como agente de diagnostico.
BR9903472A (pt) Proceso de obtenção das ligninas tetraidrofurânicas veraguensina (1) e grandisina (2), atividade antichagásica e seu uso como anthichagásico
程秋云 et al. Remission of Abdominal Colic During Enteroscopy by Injecting Vitamin K_3 into Zusanli Acupoint
ATE318612T1 (de) Methoden und zusammensetzungen zur behandlung der hyperlipidämie
NZ523676A (en) Use of cetyl myristate and cetyl palmitate to treat irritable bowel syndrome or irritable bowel disease
UA34129A (uk) Антидіарейний засіб "силоглюкан"
FR2592793A1 (fr) Association de sulpiride et de diazepam a titre de composition pharmaceutique, notamment utile dans le traitement des manifestations fonctionnelles digestives liees au stress, et son utilisation pour la preparation de ladite composition.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties